NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Enzyme identified that activates cancer cell growth and invasion



March 3rd, 2005

Researchers from Tufts-New England Medical Center, Boston, Massachusetts, have identified a long-sought-after enzyme that interacts with a specific protease-activated receptor, PAR1, on breast cancer cells.

The study authors identified metalloprotease-1 as the molecular scissors that activates PAR1, resulting in cancer cell invasion and tumor growth.

They were able to block the spread of the breast cancer in animals using novel compounds called pepducins that act on the inside surface of the cell downstream of the enzyme and receptor. Their study appeared in the February 11, 2005, edition of the journal Cell.

PARs comprise...


Source: Women's Health Weekly (2005-03-03)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login